Latest Articles

A new study conducted by researchers at Paris’s Sorbonne University, alongside colleagues from the US and Australia has now suggested that magnetic stimulation may be able to help the brain repair itself. What’s more, the team has gone one step further by identifying a molecule that they suggest may mediate this healing effect.

At first glance this question might seem like a no-brainer. Surely if you make an infectious disease notifiable then you are better able to contain infection and prevent it spreading, right? Unfortunately, whilst the principle seems simple, the reality is far less so. Here we take a look at the different facets and implications of making an infectious disease notifiable.

Scientists can now use super-resolution microscopy to directly observe living subcellular structures and activities. In this piece, we explore the basics of three popular super-resolution techniques.

In this article, we explore how pharmaceutical companies have started to embrace a more collaborative way of working as part of a movement to help overcome some of the challenges the industry is facing.

Wouldn't it be grand if it could be Christmas every day? Well, for one researcher, it sort of is. Meet Plant Pathologist and Extension Specialist Professor Gary Chastagner, also commonly referred to as "Mr Christmas Tree", a scientist who researches Christmas trees 365 days a year.

"Biosecurity” encompasses a wide range of important topics, from bioterrorism to invasive alien species of both plants and animals. But for the purposes of this article, we are going to focus on the prevention of outbreaks of disease and how to minimize the spread when they do inevitably happen.

When it comes to testing for infectious diseases, it seems some companies are engaged in a “race to the bottom” to provide the cheapest test possible. Ever-lower price points might be attractive for cash-strapped governments, NGOs and charities engaged in the ongoing fight against infectious diseases, but are such practices putting us at risk of compromising quality?

Professor David Nutt has never been afraid to stick his head above the parapet on the topic of drugs. His repeated calling-out of the failures of contemporary drug policy has seen him butt heads with academics and politicians alike. In this interview with Professor Nutt, we discuss pot, policy and the potential of psilocybin.

In the post-genomic era, the direct cost associated with performing sequencing reactions has diminished, whereas the data processing, storage, management, and interpretation costs have increased exponentially. In this article, we explore how new tools are simplifying the process of genomic data analysis.

We’re now somewhere between the second and third attempt at the UK leaving the EU. Yet, as we approach the turn of the year, the future remains opaque. What impact will Brexit have on the life sciences sector?